Jove
Visualize
Contact Us

Related Concept Videos

Drug Regulation01:25

Drug Regulation

3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

246
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
246
Drug Nomenclature01:17

Drug Nomenclature

3.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.6K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

275
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
275
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

410
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
410
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

456
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
456

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of different promoters to improve AAV vector-mediated gene therapy for neuronopathic Gaucher disease.

Human molecular genetics·2024
Same author

A Multifaceted Approach to Improve Physician Communication Scores.

Journal of patient experience·2020
Same author

Assessment of knowledge and perception about silver diamine fluoride (SDF) for treating older adults among graduating dental students.

Journal of dental education·2020
Same author

Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation.

Stem cells translational medicine·2019
Same author

Translation and validation of the Greek version of an ageism scale for dental students (ASDS_Gr).

Gerodontology·2019
Same author

Dual institution validation of an ageism scale for dental students.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·2018
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 9, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K

Data Standardization, Pharmaceutical Drug Development, and the 3Rs.

Laura Kaufman1, Katrina Gore1, Joyce Chandler Zandee1

  • 1Laura Kaufman, PhD, DABT, is an independent consultant based out of New Jersey. Katrina Gore, BSc, MSc, is the founder of KDL Gore Solutions Ltd, Hertfordshire, England. Joyce Chandler Zandee, MS, is Chief Operating Officer at Integrated Nonclinical Development Solutions, Inc, Ann Arbor, Michigan.

ILAR Journal
|January 6, 2017
PubMed
Summary
This summary is machine-generated.

Standardized data formats, like Study Data Standards (SEND) and Study Data Tabulation Model (SDTM), improve the translation of animal toxicology to human clinical trials. This enhances drug development and optimizes animal research by enabling better data access and sharing.

Keywords:
Bayesian methodsCDISCPhUSESDTMSENDdata warehousenonclinicaltoxicology

More Related Videos

An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion
08:29

An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion

Published on: March 31, 2022

5.0K
Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research
04:50

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research

Published on: August 4, 2023

1.7K

Related Experiment Videos

Last Updated: Mar 9, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K
An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion
08:29

An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion

Published on: March 31, 2022

5.0K
Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research
04:50

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research

Published on: August 4, 2023

1.7K

Area of Science:

  • Drug Development
  • Toxicology
  • Regulatory Science

Background:

  • Limited comparison exists between animal toxicology and human clinical trial findings.
  • Data accessibility and curation challenges hinder the translation of nonclinical safety data.
  • Diverse terminologies and data platforms impede cross-study analysis.

Purpose of the Study:

  • To highlight the potential of data standardization in drug development.
  • To address challenges in translating nonclinical safety data to human trials.
  • To promote efficient data sharing and utilization in research.

Main Methods:

  • Discusses the role of CDISC standards: Study Data Standards (SEND) and Study Data Tabulation Model (SDTM).
  • Explains how these standards facilitate data access and integration.
  • Highlights the upcoming FDA mandate for standardized study data.

Main Results:

  • Standardized data facilitates feasible data access and integration across studies.
  • Consistent data standards prevent data silos, promoting data sharing.
  • Maximizes the value derived from both animal and human data.

Conclusions:

  • CDISC SEND and SDTM standards are crucial for advancing drug development.
  • Standardization enables better translation of nonclinical findings to clinical applications.
  • These advancements offer opportunities to refine animal research methodologies.